Keyphrases
Respiratory Syncytial Virus Infection
100%
Clinical Disease
100%
TNF Receptor 1 (TNFR1)
100%
Bronchoconstriction
100%
Respiratory Syncytial Virus
57%
Tumor Necrosis Factor-α
42%
Interleukin-1β
28%
TNF Receptor 2 (TNFR2)
28%
Major Contributor
14%
Inflammation
14%
Inflammatory Cytokines
14%
Mouse Model
14%
CCL3
14%
Lung
14%
Chemokines
14%
Neutrophils
14%
Alveolar Macrophages
14%
Interleukin-6
14%
Cell Death
14%
Activation Status
14%
Potential Therapeutics
14%
Inflammatory Chemokines
14%
Balb C Mice
14%
Carbon Tetrachloride
14%
Respiratory Syncytial Virus Bronchiolitis
14%
Airway Disease
14%
Bronchiolitis
14%
Protective Behavior
14%
Young children
14%
Infant Patients
14%
Virus Inoculation
14%
Neutrophil Activation
14%
Antibody-mediated
14%
CCL5
14%
CXCL1
14%
Macrophage Survival
14%
CXCL2
14%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Respiratory Syncytial Virus Infection
100%
Tumor Necrosis Factor
60%
Chemokine
40%
Bronchiolitis
40%
Interleukin-1
40%
Mouse
20%
Mouse Model
20%
Interleukin-6
20%
Alveolar Macrophage
20%
Cell Death
20%
Bagg Albino Mouse
20%
Neutrophil
20%
Inflammatory Cytokine
20%
Leukocyte Activation
20%
Tumor Necrosis Factor Receptor 1
20%